Bayer props up sagging radionuclide business with Noria acqu...

Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofig

MorphoSys offers $1.7bn for Constellation, but investors see...

Shares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to buy its US rival Constellation Pharma and its pipeline of cancer and haematology therapie

Ashfield Engage acquires US consulting firm Nuvera LLC

Vectura agrees $1.4bn takeover by private equity group Carly...

Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion). 

UK competition watchdog probes AstraZeneca, Alexion merger

The antitrust authority in the UK has launched an investigation into the proposed $39 billion takeover of US firm Alexion by AstraZeneca.

Under-pressure GSK sells stake in respiratory diseases partn...

GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two.